Skip to search formSkip to main contentSkip to account menu

atoxysclerol

Known as: aetoxisclerol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A 69-year-old woman without medical history, was admitted in our emergency department for acute respiratory distress. Two weeks… 
2011
2011
Aetoxisclerol (or Polidocanol in usual medical terms) is an intermediate sclerosing agent that contains a hydrophilic and a… 
2006
2006
A 35-year-old woman has suffered from faintness with cardiovascular failure at the end of a sclerotherapy session for varix… 
Review
2004
Review
2004
PURPOSE To evaluate the efficacy of percutaneous sclerotherapy for the treatment of venous malformations (VMs) with regards to… 
1995
1995
To evaluate the efficiency of Aetoxisclerol 4% in the treatment of the great saphenous veins versus Sotradecol 3%. 
1980
1980
The author used Aetoxisclerol in the treatment of 35 patients suffering from hemorrhoids. The indications were: hemorrhages… 
1978
1978
Polydocanol is a sclerosing product recently introduced in France. It is less efficient in treating large or medium-sized…